Table 1.
Patient demographics and clinical characteristics
| Preintervention n = 5612 | Intervention n = 3036 | P | |
|---|---|---|---|
| Study site | <.001 | ||
| 1 | 492 (9.0%) | 467 (15.5%) | |
| 2 | 1072 (19%) | 673 (22.0%) | |
| 3 | 1162 (21%) | 577 (19.0%) | |
| 4 | 369 (6.5%) | 165 (5.5%) | |
| 5 | 856 (15.0%) | 474 (15.5%) | |
| 6 | 841 (15.0%) | 316 (10.5%) | |
| 7 | 820 (14.5%) | 364 (12.0%) | |
| Age (y), mean (standard deviation) | 74.0 (16.7) | 75.3 (15.6) | <.001 |
| Male sex | 2634 (47.0%) | 1350 (44.5%) | .03 |
| Australasian triage scale (maximum waiting time for medical assessment) | .007 | ||
| 1 (immediate) | 75 (1.3%) | 33 (1.1%) | |
| 2 (10 min) | 994 (17.7%) | 593 (19.5%) | |
| 3 (30 min) | 2910 (52%) | 1520 (50.0%) | |
| 4 (60 min) | 1491 (26.6%) | 804 (26.5%) | |
| 5 (120 min) | 61(1.0%) | 56 (1.9%) | |
| Unknown | 81 (1.4%) | 30 (1.0%) | |
| Charlson comorbidity index | 5 (3–7) | 5 (4–7) | .08 |
| Number of regular medications at admission | 8 (4–11) | 8 (5–11) | <.001 |